Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.86 -0.02 (-1.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Invested Capital (2021)

Cardiol Therapeutics' (CRDL) quarterly Invested Capital came in at $3.9 million in Q4 2021.

Cardiol Therapeutics (CRDL) Invested Capital (2021) Analysis & Trends

Cardiol Therapeutics (CRDL) has 1 years of Invested Capital data on file, last reported at $3.9 million in Q4 2021.

  • Quarterly Invested Capital changed N/A year-over-year to $3.9 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $3.9 million (changed N/A YoY) and the FY2021 annual result came in at $4.0 million, changed N/A from the prior year.
  • Invested Capital held at $3.9 million in Q4 2021.
  • In the past five years, Invested Capital ranged from a high of $3.9 million in Q4 2021 to a low of $3.9 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 9.90 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 4.50 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 3.74 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 1.74 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 73.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 630.00 Mn
10 Cardiol Therapeutics 214.93 Mn 196.07 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 3.95 Mn